Expertise in
6
conditions

Toshko J. Lissitchkov

BG 
Expertise in
6
conditions
BG 

Overview

Toshko Lissitchkov practices practicing medicine in Bulgaria.

Lissitchkov is highly rated in 6 conditions, according to our data. Their clinical expertise encompasses Blood Clots, Hemophilia A, Hemophilia B, and Congenital Afibrinogenemia.

They are actively involved in clinical research, co-authoring 41 peer reviewed articles and participating in 2 clinical trials.

Locations

Bulgaria
Other Locations
Sofia, Bulgaria

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura
A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura
Enrollment Status: Completed
Publish Date: December 11, 2023
Intervention Type: Drug
Study Drug: Fostamatinib
Study Phase: Phase 3
A Prospective, Multicenter, Open-label, Single-arm Study to Evaluate the Efficacy and Safety of Human Plasma-derived Fibrinogen Concentrate (FIB Grifols) in Subjects With Congenital Afibrinogenaemia and Severe Hypofibrinogenemia Requiring Either On-demand Treatment for Acute Bleeding or Surgical Prophylaxis
A Prospective, Multicenter, Open-label, Single-arm Study to Evaluate the Efficacy and Safety of Human Plasma-derived Fibrinogen Concentrate (FIB Grifols) in Subjects With Congenital Afibrinogenaemia and Severe Hypofibrinogenemia Requiring Either On-demand Treatment for Acute Bleeding or Surgical Prophylaxis
Enrollment Status: Withdrawn
Publish Date: October 23, 2023
Intervention Type: Biological
Study Phase: Phase 3
View 1 Less Clinical Trial

41 Total Publications

Individual Comparative PK Evaluation of Single-dose Octocog Alfa, Rurioctocog Alfa Pegol, and Efanesoctocog Alfa in Adults with Severe Hemophilia A.
Individual Comparative PK Evaluation of Single-dose Octocog Alfa, Rurioctocog Alfa Pegol, and Efanesoctocog Alfa in Adults with Severe Hemophilia A.
Journal: TH open : companion journal to thrombosis and haemostasis
Published: March 31, 2026

Frequently Asked Questions about Toshko J. Lissitchkov

Is Toshko J. Lissitchkov a top-rated expert for Blood Clots?

MediFind is an objective health platform that identifies experts based on real-world data. Toshko J. Lissitchkov is classified as an Elite expert for Blood Clots, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Toshko J. Lissitchkov participate in research or clinical trials?

Yes. Toshko J. Lissitchkov has published 41 articles and abstracts on conditions like Blood Clots. You can view a list of Toshko J. Lissitchkov's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Lissitchkov's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile